In Phase 3 trials so far, its delivered up to 28.7% body-weight loss at 68 weeks at the 12 mg dose in adults with obesity and knee osteoarthritis, alongside meaningful reductions in knee pain
* Values are calculated based on 2,000 kcal/day and may vary depending on gender, age, and physical activity
Adding Tesofensine can provide the sympathetic drive needed to increase resting energy expenditure, while adding 5-Amino-1MQ can optimize cellular metabolism, effectively breaking the plateau without compromising patient comfort
Ongoing post-marketing surveillance and long-term clinical trials are crucial to understanding the broader implications of its use over time, particularly concerning the management of chronic conditions like IBS, diabetes, and obesity
Where can L-carnitine be found